Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 11INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 927Neoplasms 609Breast Neoplasms 605Colorectal Neoplasms 458Neoplasm Metastasis 394Ovarian Neoplasms 328Melanoma 313Prostatic Neoplasms 311Lung Neoplasms 294Multiple Myeloma 292Recurrence 278Squamous Cell Carcinoma of Head and Neck 246Stomach Neoplasms 229Pancreatic Neoplasms 229Leukemia, Myeloid, Acute 220Triple Negative Breast Neoplasms 191Endometrial Neoplasms 190Carcinoma, Renal Cell 182Lymphoma, Non-Hodgkin 179Carcinoma, Hepatocellular 177Small Cell Lung Carcinoma 165Leukemia, Lymphocytic, Chronic, B-Cell 156Advanced Solid Tumors 156Lymphoma, Follicular 148Urinary Bladder Neoplasms 139Lymphoma, Large B-Cell, Diffuse 138Lymphoma 137Advanced Solid Tumor 137Uterine Cervical Neoplasms 134Head and Neck Neoplasms 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Intellectual Disability × 1 year × Clear all
NCT07092852 2025-07-30

PGx Medication Safety Reviews of Persons With IDD

GalenusRx, Inc.

Not yet recruiting
700 enrolled
Lymphoid

Developmental Disabilities, Lymphoma, Follicular, Intellectual Disability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡